Mesothelioma Surgery with Organ Removal Extends Survival

Treatment & Doctors
Reading Time: 6 mins
Publication Date: 11/17/2020
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us

Testimonials

"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Lashawn
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite Asbestos.com’s Article

APA

Povtak, T. (2021, March 11). Mesothelioma Surgery with Organ Removal Extends Survival. Asbestos.com. Retrieved October 6, 2022, from https://www.asbestos.com/news/2020/11/17/mesothelioma-organ-removal-survival/

MLA

Povtak, Tim. "Mesothelioma Surgery with Organ Removal Extends Survival." Asbestos.com, 11 Mar 2021, https://www.asbestos.com/news/2020/11/17/mesothelioma-organ-removal-survival/.

Chicago

Povtak, Tim. "Mesothelioma Surgery with Organ Removal Extends Survival." Asbestos.com. Last modified March 11, 2021. https://www.asbestos.com/news/2020/11/17/mesothelioma-organ-removal-survival/.

Removing major organs to achieve a more complete cancer resection did not increase severe complications or hinder survival benefits of aggressive surgery for patients with peritoneal mesothelioma, according to a recent report.

The increased complexity of organ resection surgery will not adversely affect long-term outcomes, according to the multicenter study published in Annals of Surgical Oncology.

By comparison, an incomplete cytoreduction that can spare the organs is associated with increased mortality and shorter overall survival.

The study, which involved 174 patients across 12 specialty centers within the U.S., accentuated a growing trend that has dramatically improved the treatment of peritoneal mesothelioma in recent years.

Peritoneal mesothelioma is an aggressive cancer that starts in the lining of the abdomen and often metastasizes to surrounding organs.

A combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, known as HIPEC, has become the most effective way of treating it, allowing patients to survive anywhere from two to 10 years and beyond after diagnosis.

Without aggressive treatment, however, median survival is just six to 12 months.

“The results of the study were pretty consistent with what we expected to see. That’s encouraging,” co-author Dr. Sean Dineen, surgical oncologist and specialist at Moffitt Cancer Center in Tampa, told The Mesothelioma Center at Asbestos.com. “I think they really justify extensive resection, if necessary, to achieve a complete cytoreduction.”

Moffitt Cancer Center a Leader in Mesothelioma Treatment

Dineen is part of the Department of Gastrointestinal Oncology at Moffitt Cancer Center. He specializes in peritoneal diseases such as mesothelioma.

“We go into surgery knowing the operation may be extensive, but you always try to balance the extent of the surgery with the benefit the patient will receive from it,” Dineen said. “These results support going ahead with aggressive resection.”

Complete cytoreduction aims to remove all visible disease. In achieving that goal, however, resection of one or more abdominal organs may be necessary.

The HIPEC that follows involves a high-dose chemotherapy solution that is circulated throughout the abdominal cavity for 90 minutes immediately following surgery and then removed. The intent is to kill any microscopic tumor cells that evade the surgeon.

Mesothelioma Survival Rates Rising with Surgery

A slight majority of patients in the study (54%) underwent a peritoneal resection only, which involved removing the internal lining of the abdomen where the disease typically begins. That group was called MOR-0.

Another 25.9% of patients had one major organ removed (MOR-1) and 20.1% had two or more major organs removed (MOR-2) as part of their procedure.

Major organ removal was defined as total or partial resection of the diaphragm, stomach, spleen, pancreas, small bowel, colon, rectum, kidney, ureter, bladder and/or uterus.

Those organs are often where peritoneal mesothelioma has metastasized over time. The most common removals were uterus and colon.

The study found that the MOR-1 and MOR-2 groups had a higher frequency of post-surgery complications than MOR-0, but the number of major complications was similar for each group. The length of hospital stay also was slightly longer for MOR-1 and MOR-2.

Readmission rates within 90 days was not affected by MOR status. MOR was not associated with any 30-day mortality.

Median overall survival was 86 months, which included 130 months for MOR-0, 56 months for MOR-1 and 93 months for MOR-2.

The study concluded that the extent of surgery measured by MOR was not a determining factor of overall survival. A univariate analysis cited age, sex and overall health as the greatest drivers of overall survival.

Study Included Top Cancer Specialty Centers

Treatment centers involved in the study included:

Dineen emphasized the importance of finding a high-volume treatment center experienced with this rare cancer. Finding a mesothelioma specialist can be especially important in terms of overall survival.

“I’m biased, but when you look at the extent of the surgery frequently required, it does argue you should be at a center that has experience to do these procedures as safely as possible,” Dineen said. “The results of this study are what you should expect from a specialized center.”

The increased complexity of organ resection surgery will not adversely affect long-term outcomes, according to the multicenter study published in Annals of Surgical Oncology.

By comparison, an incomplete cytoreduction that can spare the organs is associated with increased mortality and shorter overall survival.

The study, which involved 174 patients across 12 specialty centers within the U.S., accentuated a growing trend that has dramatically improved the treatment of peritoneal mesothelioma in recent years.

Peritoneal mesothelioma is an aggressive cancer that starts in the lining of the abdomen and often metastasizes to surrounding organs.

A combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, known as HIPEC, has become the most effective way of treating it, allowing patients to survive anywhere from two to 10 years and beyond after diagnosis.

Without aggressive treatment, however, median survival is just six to 12 months.

“The results of the study were pretty consistent with what we expected to see. That’s encouraging,” co-author Dr. Sean Dineen, surgical oncologist and specialist at Moffitt Cancer Center in Tampa, told The Mesothelioma Center at Asbestos.com. “I think they really justify extensive resection, if necessary, to achieve a complete cytoreduction.”

Moffitt Cancer Center a Leader in Mesothelioma Treatment

Dineen is part of the Department of Gastrointestinal Oncology at Moffitt Cancer Center. He specializes in peritoneal diseases such as mesothelioma.

“We go into surgery knowing the operation may be extensive, but you always try to balance the extent of the surgery with the benefit the patient will receive from it,” Dineen said. “These results support going ahead with aggressive resection.”

Complete cytoreduction aims to remove all visible disease. In achieving that goal, however, resection of one or more abdominal organs may be necessary.

The HIPEC that follows involves a high-dose chemotherapy solution that is circulated throughout the abdominal cavity for 90 minutes immediately following surgery and then removed. The intent is to kill any microscopic tumor cells that evade the surgeon.

Mesothelioma Survival Rates Rising with Surgery

A slight majority of patients in the study (54%) underwent a peritoneal resection only, which involved removing the internal lining of the abdomen where the disease typically begins. That group was called MOR-0.

Another 25.9% of patients had one major organ removed (MOR-1) and 20.1% had two or more major organs removed (MOR-2) as part of their procedure.

Major organ removal was defined as total or partial resection of the diaphragm, stomach, spleen, pancreas, small bowel, colon, rectum, kidney, ureter, bladder and/or uterus.

Those organs are often where peritoneal mesothelioma has metastasized over time. The most common removals were uterus and colon.

The study found that the MOR-1 and MOR-2 groups had a higher frequency of post-surgery complications than MOR-0, but the number of major complications was similar for each group. The length of hospital stay also was slightly longer for MOR-1 and MOR-2.

Readmission rates within 90 days was not affected by MOR status. MOR was not associated with any 30-day mortality.

Median overall survival was 86 months, which included 130 months for MOR-0, 56 months for MOR-1 and 93 months for MOR-2.

The study concluded that the extent of surgery measured by MOR was not a determining factor of overall survival. A univariate analysis cited age, sex and overall health as the greatest drivers of overall survival.

Study Included Top Cancer Specialty Centers

Treatment centers involved in the study included:

Dineen emphasized the importance of finding a high-volume treatment center experienced with this rare cancer. Finding a mesothelioma specialist can be especially important in terms of overall survival.

“I’m biased, but when you look at the extent of the surgery frequently required, it does argue you should be at a center that has experience to do these procedures as safely as possible,” Dineen said. “The results of this study are what you should expect from a specialized center.”

Medically Reviewed by Top Mesothelioma Doctors
Free Mesothelioma Guide